FORM DEF 14A

Company

UroGen Pharma Ltd.

Filed

July 1, 2024

Period of Report

August 7, 2024

Accession Number

0001437749-24-021722

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →